These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33191077)

  • 1. Chronic nicotine, but not suramin or resveratrol, partially remediates the mania-like profile of dopamine transporter knockdown mice.
    Kwiatkowski MA; Roberts BZ; van Enkhuizen J; Ji B; Zhou X; Young JW
    Eur Neuropsychopharmacol; 2021 Jan; 42():75-86. PubMed ID: 33191077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration.
    Young JW; Goey AK; Minassian A; Perry W; Paulus MP; Geyer MA
    Pharmacol Biochem Behav; 2010 Jul; 96(1):7-15. PubMed ID: 20363246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine transporter knockdown mice in the behavioral pattern monitor: A robust, reproducible model for mania-relevant behaviors.
    Kwiatkowski MA; Hellemann G; Sugar CA; Cope ZA; Minassian A; Perry W; Geyer MA; Young JW
    Pharmacol Biochem Behav; 2019 Mar; 178():42-50. PubMed ID: 29289701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brexpiprazole reduces hyperactivity, impulsivity, and risk-preference behavior in mice with dopamine transporter knockdown-a model of mania.
    Milienne-Petiot M; Geyer MA; Arnt J; Young JW
    Psychopharmacology (Berl); 2017 Mar; 234(6):1017-1028. PubMed ID: 28160035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania.
    Young JW; van Enkhuizen J; Winstanley CA; Geyer MA
    J Psychopharmacol; 2011 Jul; 25(7):934-43. PubMed ID: 21421642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic valproate attenuates some, but not all, facets of mania-like behaviour in mice.
    van Enkhuizen J; Geyer MA; Kooistra K; Young JW
    Int J Neuropsychopharmacol; 2013 Jun; 16(5):1021-31. PubMed ID: 23164454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine depletion attenuates some behavioral abnormalities in a hyperdopaminergic mouse model of bipolar disorder.
    van Enkhuizen J; Geyer MA; Halberstadt AL; Zhuang X; Young JW
    J Affect Disord; 2014 Feb; 155():247-54. PubMed ID: 24287168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior.
    Young JW; Goey AK; Minassian A; Perry W; Paulus MP; Geyer MA
    Psychopharmacology (Berl); 2010 Feb; 208(3):443-54. PubMed ID: 20020109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling bipolar disorder in mice by increasing acetylcholine or dopamine: chronic lithium treats most, but not all features.
    van Enkhuizen J; Milienne-Petiot M; Geyer MA; Young JW
    Psychopharmacology (Berl); 2015 Sep; 232(18):3455-67. PubMed ID: 26141192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic antipsychotic treatment exerts limited effects on the mania-like behavior of dopamine transporter knockdown mice.
    Cope ZA; Kenton JA; Minassian A; Martin MV; Perry W; Bundgaard C; Arnt J; van Enkhuizen J; Geyer MA; Young JW
    Behav Brain Res; 2021 May; 405():113167. PubMed ID: 33577882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convergent neural substrates of inattention in bipolar disorder patients and dopamine transporter-deficient mice using the 5-choice CPT.
    Young JW; Geyer MA; Halberstadt AL; van Enkhuizen J; Minassian A; Khan A; Perry W; Eyler LT
    Bipolar Disord; 2020 Feb; 22(1):46-58. PubMed ID: 31025493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of reduced dopamine transporter function and chronic lithium on motivation, probabilistic learning, and neurochemistry in mice: Modeling bipolar mania.
    Milienne-Petiot M; Kesby JP; Graves M; van Enkhuizen J; Semenova S; Minassian A; Markou A; Geyer MA; Young JW
    Neuropharmacology; 2017 Feb; 113(Pt A):260-270. PubMed ID: 27732870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of dopamine D
    Milienne-Petiot M; Groenink L; Minassian A; Young JW
    J Psychopharmacol; 2017 Oct; 31(10):1334-1346. PubMed ID: 28950781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mice with reduced DAT levels recreate seasonal-induced switching between states in bipolar disorder.
    Young JW; Cope ZA; Romoli B; Schrurs E; Aniek Joosen ; van Enkhuizen J; Sharp RF; Dulcis D
    Neuropsychopharmacology; 2018 Jul; 43(8):1721-1731. PubMed ID: 29520059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced dopamine transporter functioning induces high-reward risk-preference consistent with bipolar disorder.
    van Enkhuizen J; Henry BL; Minassian A; Perry W; Milienne-Petiot M; Higa KK; Geyer MA; Young JW
    Neuropsychopharmacology; 2014 Dec; 39(13):3112-22. PubMed ID: 25005251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men.
    Perry W; Minassian A; Paulus MP; Young JW; Kincaid MJ; Ferguson EJ; Henry BL; Zhuang X; Masten VL; Sharp RF; Geyer MA
    Arch Gen Psychiatry; 2009 Oct; 66(10):1072-80. PubMed ID: 19805697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mood stabilizer valproic acid opposes the effects of dopamine on circadian rhythms.
    Landgraf D; Joiner WJ; McCarthy MJ; Kiessling S; Barandas R; Young JW; Cermakian N; Welsh DK
    Neuropharmacology; 2016 Aug; 107():262-270. PubMed ID: 27033596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system.
    Ralph-Williams RJ; Paulus MP; Zhuang X; Hen R; Geyer MA
    Biol Psychiatry; 2003 Feb; 53(4):352-9. PubMed ID: 12586455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional alterations of nicotinic neurotransmission in dopamine transporter knock-out mice.
    Weiss S; Tzavara ET; Davis RJ; Nomikos GG; Michael McIntosh J; Giros B; Martres MP
    Neuropharmacology; 2007 Jun; 52(7):1496-508. PubMed ID: 17433376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Positron Emission Tomography Study of Dopamine Transporter Density in Patients With Bipolar Disorder With Current Mania and Those With Recently Remitted Mania.
    Yatham LN; Liddle PF; Gonzalez M; Saraf G; Vafai N; Lam RW; Sossi V
    JAMA Psychiatry; 2022 Dec; 79(12):1217-1224. PubMed ID: 36322065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.